Krabeva 400mg Injection
Marketer
Biocon
Salt Composition
Bevacizumab (400mg)
Overview Krabeva 400mg Injection
OncoVasc 400mg Injection is a cancer treatment agent. Indicated for colorectal, non-small cell lung, renal, brain, ovarian, and cervical cancers, it inhibits tumor angiogenesis, thus hindering tumor growth. Highly effective as a first-line therapy in conjunction with other antineoplastic agents, OncoVasc 400mg Injection is administered intravenously via infusion, either directly into a vein or through a subcutaneous port. Dosage and treatment duration are determined by your physician, who will monitor for infusion reactions like hypertension and respiratory distress. Continued use depends on disease control and manageable side effects, with discontinuation determined solely by your doctor. Regular monitoring of blood pressure and urinary protein levels may be advised. Common adverse effects include rectal hemorrhage, altered taste perception, and cephalalgia. Pre-surgical notification of OncoVasc 400mg Injection use is crucial due to its potential to impair wound healing; it also increases bleeding risk, so report any unusual bleeding immediately. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor. Inform your healthcare provider of all other medications you are taking, as drug interactions are possible.
Uses of Krabeva 400mg Injection
Colorectal cancer, ovarian neoplasm, cervical carcinoma, renal cell carcinoma, intracranial tumor, and non-small cell lung carcinoma.
Major Benefits of Krabeva 400mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Krabeva 400mg Injection:
- Exfoliative dermatitis
- High blood pressure
- Nosebleeds
- Protein in urine
- Decreased appetite
- Electrolyte imbalance
- Peripheral sensory neuropathy
- Breathlessness
- Thromboembolism
- Wound healing complications
- Ovarian failure
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Mucosal inflammation
- Abscess
- Cellulitis
- Hypersensitivity
- Rectovaginal fistula
How to use Krabeva 400mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Krabeva 400mg Injection works:
Krabeva 400mg Injection, an anti-angiogenesis agent, inhibits vascular endothelial growth factor (VEGF), thereby preventing the development of new blood vessels that supply tumors with oxygen and essential nutrients.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Krabeva 400mg Injection with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Krabeva 400mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Krabeva 400mg Injection while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administration of Krabeva 400mg Injection may induce adverse reactions that could compromise driving capabilities. Instances of drowsiness and syncope have been documented following Krabeva 400mg Injection, potentially affecting safe driving.
KidneySAFE IF PRESCRIBED
The use of Krabeva 400mg Injection in individuals with kidney impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Krabeva 400mg Injection in individuals with hepatic impairment is likely safe. Available evidence indicates that dose modification may not be necessary for this patient group. Physician consultation is recommended.
What if you forget to take Krabeva 400mg Injection :
Omitting a scheduled dose of Krabeva 400mg Injection warrants immediate physician consultation.
Facts to Know About Krabeva 400mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | VEGF-blocking agent |
3,018 People bought this recently